|
ZNF709 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.88530000003284E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.25140000000335E-05 |
| Normal-vs-Stage2 |
5.821800E-04 |
| Normal-vs-Stage3 |
1.78719999999188E-06 |
| Normal-vs-Stage4 |
9.08249999986843E-07 |
| Stage1-vs-Stage2 |
7.439200E-01 |
| Stage1-vs-Stage3 |
5.314300E-02 |
| Stage1-vs-Stage4 |
2.164800E-03 |
| Stage2-vs-Stage3 |
2.476000E-01 |
| Stage2-vs-Stage4 |
4.350400E-02 |
| Stage3-vs-Stage4 |
4.279800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.36790000002407E-06 |
| Normal-vs-AfricanAmerican |
2.024500E-04 |
| Normal-vs-Asian |
7.376200E-04 |
| Caucasian-vs-AfricanAmerican |
4.721000E-01 |
| Caucasian-vs-Asian |
3.075600E-01 |
| AfricanAmerican-vs-Asian |
1.882020E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.31649999977202E-08 |
| Normal-vs-Female |
7.753000E-04 |
| Male-vs-Female |
1.718610E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.91519999999512E-05 |
| Normal-vs-Extreme_Weight |
4.59389999996063E-06 |
| Normal-vs-Obese |
1.182670E-04 |
| Normal-vs-Extreme_Obese |
2.997700E-03 |
| Normal_Weight-vs-Extreme_Weight |
9.042800E-01 |
| Normal_Weight-vs-Obese |
5.180200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.313400E-01 |
| Extreme_Weight-vs-Obese |
3.570600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.666200E-01 |
| Obese-vs-Extreme_Obese |
7.542800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.158550E-04 |
| Normal-vs-Age(41-60Yrs) |
2.779000E-04 |
| Normal-vs-Age(61-80Yrs) |
2.83990000404799E-08 |
| Normal-vs-Age(81-100Yrs) |
9.84090000000215E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.463800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.782000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.012600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.694420E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.638970E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.664400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.790330E-04 |
| Normal-VS-Type2 PRCC |
9.32365296080206E-13 |
| Normal-VS-KIRP CIMP |
2.28869999951975E-07 |
| Normal-VS-Unclassified PRCC |
1.311630E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.55169999469263E-08 |
| Type1 PRCC-VS-KIRP CIMP |
1.377450E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
8.956600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.241800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.521700E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
8.555600E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.92640003948696E-09 |
| Normal-vs-N1 |
2.4274999999907E-05 |
| Normal-vs-N2 |
5.94050000000124E-05 |
| N0-vs-N1 |
9.082200E-01 |
| N0-vs-N2 |
3.256200E-02 |
| N1-vs-N2 |
1.197220E-01 |
|
|
